Re[2]: Vaccination & Homeopathicprophylaxis
Posted: Wed Jun 07, 2006 10:58 am
Hello Shannon,
Time is short so I will respond the best I can.
Monday, June 5, 2006, 11:44:58 PM, you wrote:
RSN> E.g. you write:
RSN> Immunisation by HP only, was associated with a lower than average
RSN> chance of acquiring asthma or eczema and less risk of developing
RSN> allergies.
RSN> 2. The incidence of asthma (3%) in children who were immunised only by
RSN> HP was well below the national average of 19%.
RSN> 3. The incidence of behavioural problems in children immunised by HP
RSN> was extremely low compared to the other methods of immunisation.
RSN> 4. In relation to asthma, immunising a child with HP alone was 15 times
RSN> safer than immunising by vaccines, and 6 times safer than doing nothing
RSN> for immunisation.
RSN> 5. In relation to eczema, immunising only with HP was 7.4 times safer
RSN> than immunising with vaccines and 2.8 times safer than doing nothing
RSN> about immunisation.
RSN> 6. In relation to allergies, immunising only with HP was 5 times safer
RSN> than by vaccines and 2 times safer than no method of immunisation.
RSN> Meaning, apparently, that the HP-treated groups had only a fraction of
RSN> the incidence of allergies, eczema, asthma, behavior disorders or
RSN> allergies, compared with the *completely unvaccinated* group--and an
RSN> even teenier fraction of the incidence in the conventionally vaccinated
RSN> group.
You will have to obtain Isaac's studies to understand completely what
is stated above - they are available in book/manual/treatise form and,
as with any data and analysis requires lengthy reading and
concentration. The above statements are conclusions that have been
drawn from the research. I asked Isaac to check the facts in my
article re his research. What you have quoted above is drawn from his
writing and considered as accurate by Isaac and those who supervised
his work.
I checked with Isaac at the time of writing the article if he was
happy for people to contact him if they had questions. He is happy to
answer any relevant questions and engage in discussion but of course,
is not interested in rewriting his research in extensive emails for
those who cannot be bothered to read it for themselves and just want
to argue (not suggesting you are in this category). In other words,
don't expect him to explain again what he has already explained in the
books. Those who are prepared to make the effort, he is more than
happy to dialogue with, whether they agree with him or not.
Briefly to say here that the different groups had varying levels of
risk/less risk, depending on which measure was being examined.
Overall, the vaccinated group fared the worst while overall, the
"natural" group was not that far behind the HP group. Overall, the HP
group was the healthiest - the degree to which this was so depended on
the measure being used and the group being compared.
RSN> I was also intrigued to read that this had been achieved with
RSN> only single doses of "low to medium" potencies.
This is a misunderstanding. The low and single potencies were from the
Brazilian study of the first article - HP for Meningococcal disease.
The Golden study of the second article generally used higher potencies
and which appear to produce longer/greater protection - more research
is needed in this area.
--
Best regards,
Fran mailto:FranSheffield@homeopathyplus.com.au
Time is short so I will respond the best I can.
Monday, June 5, 2006, 11:44:58 PM, you wrote:
RSN> E.g. you write:
RSN> Immunisation by HP only, was associated with a lower than average
RSN> chance of acquiring asthma or eczema and less risk of developing
RSN> allergies.
RSN> 2. The incidence of asthma (3%) in children who were immunised only by
RSN> HP was well below the national average of 19%.
RSN> 3. The incidence of behavioural problems in children immunised by HP
RSN> was extremely low compared to the other methods of immunisation.
RSN> 4. In relation to asthma, immunising a child with HP alone was 15 times
RSN> safer than immunising by vaccines, and 6 times safer than doing nothing
RSN> for immunisation.
RSN> 5. In relation to eczema, immunising only with HP was 7.4 times safer
RSN> than immunising with vaccines and 2.8 times safer than doing nothing
RSN> about immunisation.
RSN> 6. In relation to allergies, immunising only with HP was 5 times safer
RSN> than by vaccines and 2 times safer than no method of immunisation.
RSN> Meaning, apparently, that the HP-treated groups had only a fraction of
RSN> the incidence of allergies, eczema, asthma, behavior disorders or
RSN> allergies, compared with the *completely unvaccinated* group--and an
RSN> even teenier fraction of the incidence in the conventionally vaccinated
RSN> group.
You will have to obtain Isaac's studies to understand completely what
is stated above - they are available in book/manual/treatise form and,
as with any data and analysis requires lengthy reading and
concentration. The above statements are conclusions that have been
drawn from the research. I asked Isaac to check the facts in my
article re his research. What you have quoted above is drawn from his
writing and considered as accurate by Isaac and those who supervised
his work.
I checked with Isaac at the time of writing the article if he was
happy for people to contact him if they had questions. He is happy to
answer any relevant questions and engage in discussion but of course,
is not interested in rewriting his research in extensive emails for
those who cannot be bothered to read it for themselves and just want
to argue (not suggesting you are in this category). In other words,
don't expect him to explain again what he has already explained in the
books. Those who are prepared to make the effort, he is more than
happy to dialogue with, whether they agree with him or not.
Briefly to say here that the different groups had varying levels of
risk/less risk, depending on which measure was being examined.
Overall, the vaccinated group fared the worst while overall, the
"natural" group was not that far behind the HP group. Overall, the HP
group was the healthiest - the degree to which this was so depended on
the measure being used and the group being compared.
RSN> I was also intrigued to read that this had been achieved with
RSN> only single doses of "low to medium" potencies.
This is a misunderstanding. The low and single potencies were from the
Brazilian study of the first article - HP for Meningococcal disease.
The Golden study of the second article generally used higher potencies
and which appear to produce longer/greater protection - more research
is needed in this area.
--
Best regards,
Fran mailto:FranSheffield@homeopathyplus.com.au